(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 4% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 5.74%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.98%.
Henry Schein's revenue in 2026 is $13,602,000,000.On average, 20 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,576,411,336,590, with the lowest HSIC revenue forecast at $1,509,989,197,558, and the highest HSIC revenue forecast at $1,628,233,978,620. On average, 20 Wall Street analysts forecast HSIC's revenue for 2027 to be $1,639,935,865,530, with the lowest HSIC revenue forecast at $1,564,263,663,512, and the highest HSIC revenue forecast at $1,724,635,237,450.
In 2028, HSIC is forecast to generate $1,705,912,218,394 in revenue, with the lowest revenue forecast at $1,614,080,267,786 and the highest revenue forecast at $1,806,325,552,736.